Reverse right ventricular remodeling after pulmonary endarterectomy  by D’Armini, Andrea M. et al.
R
e
A
L
Surgery for Acquired Cardiovascular Disease D’Armini et al
1
A
CDeverse right ventricular remodeling after pulmonary
ndarterectomy
ndrea M. D’Armini, MD,a Giorgio Zanotti, MD,a Stefano Ghio, MD,b Giulia Magrini, MD,b Matteo Pozzi, MD,aaura Scelsi, MD,b Giulia Meloni, MD,c Catherine Klersy, MD,d and Mario Viganò, MDa
O
n
v
p
M
i
w
r
u
3
2
R
s
v
h
l
s
g
l
C
m
p
a
t
d
a
C
d
t
f
f
v
n
p
a
rFrom the Division of Cardiac Surgery,a the
Division of Cardiology,b the Institute of
Radiology,c and the Biostatistics Unit,d
University of Pavia School of Medicine,
Fondazione IRCCS San Matteo Hospital,
Pavia, Italy.
Read at the Eighty-sixth Annual Meeting of
The American Association for Thoracic
Surgery, Philadelphia, Pa, April 29-May 3,
2006.
Received for publication April 24, 2006;
revisions received Aug 27, 2006; accepted
for publication Aug 31, 2006.
Address for reprints: Andrea M. D’Armini,
MD, Division of Cardiac Surgery, Univer-
sity of Pavia School of Medicine, Fondazi-
one IRCCS San Matteo Hospital, Piazzale
Golgi 19, 27100 Pavia, Italy (E-mail:
darmini@smatteo.pv.it).
J Thorac Cardiovasc Surg 2007;133:162-8
0022-5223/$32.00
Copyright © 2007 by The American Asso-
ciation for Thoracic Surgeryp
doi:10.1016/j.jtcvs.2006.08.059
62 The Journal of Thoracic and Cardiobjectives: We sought to evaluate the capability of the right ventricle to regain
ormal morphology and function after pulmonary endarterectomy, to correlate right
entricular reverse remodeling with functional status, and to identify independent
redictors of clinical failure after surgical intervention.
ethods: From December 2000 through August 2003, 45 patients underwent
solated pulmonary endarterectomy. Morphology and function of the right ventricle
ere studied by using a combination of right heart catheterization, cardiac magnetic
esonance, and transthoracic echocardiography. Functional status was evaluated by
sing New York Heart Association class. Full preoperative data were available for
7 candidates. All patients were evaluated before discharge, at 3 months, and at 1,
, and 3 years postoperatively using the same modalities.
esults: Immediately after surgical intervention, right ventricular cavitary dimen-
ions decreased significantly, and tricuspid regurgitation radically improved. Right
entricular ejection fraction and functional status improved and right ventricular
ypertrophy reversed over a longer time period. Higher ventricular dimensions and
ower ejection fraction of the right ventricle were associated with poorer functional
tatus at any time postoperatively. At discharge, pulmonary vascular resistance of
reater than 509 dyne · sec · cm5 and right ventricular ejection fraction of 24% or
ess predicted clinical failure at 12 months’ follow-up.
onclusions: After pulmonary endarterectomy, the right ventricle recovers and
aintains normal architecture and function over time, regardless of the severity of
reoperative disease. Accurate preoperative evaluation of the hemodynamics and
natomy of the thromboembolic lesions are mandatory. If pulmonary endarterec-
omy is not expected to decrease pulmonary vascular resistance to less than 509
yne · sec · cm5, indication for surgical intervention needs to be carefully evalu-
ted.
hronic thromboembolic pulmonary hypertension (CTEPH) is a progressive
and potentially lethal disease that profoundly affects the morphology and
function of the right ventricle. Long-term survival and functional status are
ependent on the degree of pulmonary hypertension and pulmonary vascular resis-
ance (PVR) at diagnosis,1,2 which are major determinants of right ventricular
unction. Pulmonary endarterectomy (PEA) is the treatment of choice, is technically
easible in more than 70% of patients,3 and is hemodynamically successful in the
ast majority of those undergoing the procedure.3-5 Because PEA relieves pulmo-
ary hypertension, we sought to assess the capability of the right ventricle to regain
hysiologic morphology and function after surgical intervention, which we refer to
s reverse remodeling; to assess the durability of these changes; and to correlate
ight ventricular reverse remodeling with functional status. Also, we tried to identify
ostoperative predictors of clinical failure.
vascular Surgery ● January 2007
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A
CDatients and Methods
atients
rom December 2000 through August 2003, 63 patients were
valuated for PEA at our institution. Surgical intervention was
ndicated in 47 patients (operability rate, 74.6%); 45 of these
ndividuals underwent isolated PEA (1 patient refused intervention
nd 1 died during preoperative evaluation). Preoperative charac-
eristics, operative procedures, hospital outcomes, and follow-up
ata were prospectively entered into the Pavia Pulmonary Endar-
erectomy Registry. Use of this registry for research was approved
y the hospital review board. Informed consent was obtained for
ach patient included in the study. The morphology and function of
he right ventricle were studied in each patient by using a combi-
ation of right heart catheterization, cardiac magnetic resonance, and
ransthoracic echocardiography. Also, left ventricular data were
btained by means of cardiac magnetic resonance and transtho-
acic echocardiography to study ventricular interdependence. A
ull set of preoperative data was available for 37 candidates, who
epresent our initial study population (Table 1).
ndications and Operative Technique
he selection criteria for patients undergoing PEA and operative
echnique have been thoroughly described by Jamieson and kapel-
nski.5 Although the vast majority of our patients had clinically
ignificant tricuspid regurgitation, tricuspid repair was not per-
ormed because the incontinence was always deemed functional.
ight Heart Catheterization
he procedure was performed through the right internal jugular
ein by using a flow-directed, balloon-tipped Swan–Ganz catheter
7.5F; Edwards Lifesciences, Irvine, Calif). Measured parameters
ere cardiac output, as well as right atrial, right ventricular,
ulmonary artery, and capillary wedge pressures. Calculated pa-
ameters were PVR and cardiac index.
ardiac Magnetic Resonance
xaminations were performed with use of a 1.5-T unit (Siemens
agnetom, Malvern, Pa). Hearts were imaged with a body coil and
y means of spin echo sequences for morphologic evaluation.
ight ventricular measurements were obtained from the 4-chamber
ransverse plane, and left ventricular measurements were obtained
rom the short-axis plane. Volumes were measured by using the
rgus Function, a fully automated segmentation of high-contrast
rueFISP cine. For each ventricle, the ejection fraction was cal-
ulated as follows: [(End-diastolic volume  End-systolic volume)/
nd-diastolic volume] * 100. Right ventricular free-wall thickness
Abbreviations and Acronyms
CTEPH chronic thromboembolic pulmonary
hypertension
NYHA  New York Heart Association
PEA  pulmonary endarterectomy
PVR  pulmonary vascular resistanceas measured to assess the degree of hypertrophy. a
The Journal of Thoracicransthoracic Echocardiography
tandard M-mode, 2-dimensional, and Doppler studies were per-
ormed with use of a commercially available echocardiography ma-
hine (2.5 MHz probe; Vingmed GE System 5, Horten, Norway). As
n indirect index of right ventricular radial systolic function, the right
entricular fractional area shrinkage was calculated as follows: [(End-
iastolic area  End-systolic area)/End-diastolic area] * 100. The
aximum systolic displacement of the lateral portion of the tricuspid
nnular plane was measured on the M-mode tracing with 2-dimen-
ional echocardiographic guidance to evaluate the right ventricular
ongitudinal systolic function. Tricuspid regurgitation was graded by
sing the jet area method.6 The tricuspid valve was studied in multiple
iews to differentiate functional from organic regurgitation. The in-
erior vena caval diameter was measured from the subcostal view. Its
nspiratory collapse was assessed and considered preserved if greater
han 50%. To demonstrate abnormal diastolic leftward interventricu-
ar septal motion, we used the end-diastolic eccentricity index. An
nd-diastolic eccentricity index of greater than 1 was considered
athologic.7
unctional Status and Postoperative Clinical Failure
unctional status was evaluated at each time point by using the
ew York Heart Association (NYHA) classification. At discharge,
unctional status was not evaluated. Clinical failure was defined as
ersistence of NYHA class III or IV or death from right ventricular
ailure 1 year postoperatively.
ollow-up
ll patients were evaluated before discharge and then at 3 months
nd 1, 2, and 3 years postoperatively by means of right heart
atheterization, cardiac magnetic resonance, and transthoracic
chocardiography, all performed at our institution over a 2-day
eriod at each time point. Results were assessed in a masked
anner. Study follow-up ended in February 2006. Follow-up was
omplete for 35 patients at discharge and at 3 months, 34 patients
ABLE 1. Patient characteristics
haracteristic No. Percentage
emography
Sex 25 M/12 F
Age (y)* 54  14 (21-72)
isk factors (history)
DVT 30 81.1
PE 37 100.0
Autoantibodies† 12 32.4
unctional symptoms
NYHA
II 1 2.7
III 13 35.1
IV 23 62.2
NYHA III/IV duration (mo)‡ 17 (12-27)
NYHA III/IV 1 y 26 70.3
VT, Deep venous thrombosis; PE, pulmonary embolism; NYHA, New York
eart Association functional class. *Mean  standard deviation (range).
One or more of the following: anticardiolipin antibody, lupus anticoagulant
ntibody, and antiphospholipid antibody. ‡Median and 25th and 75th
ercentiles.t 1 and 2 years, and 21 patients at 3 years.
and Cardiovascular Surgery ● Volume 133, Number 1 163
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A
CDtatistical Analysis
ean and standard deviation or median and interquartile range (if
kewed) were used to describe continuous variables. Counts and
ercentages were used to describe categoric variables. Changes
rom baseline and their 95% confidence intervals were computed.
eneral linear regression models were fitted to assess changes in
YHA class, hemodynamic variables, findings on cardiac mag-
etic resonance, and echocardiographic characteristics over time.
uber/White/sandwich robust standard errors were computed to
ccount for the dependence between repeated measures in the same
atient. The association between NYHA class and right ventricular
unction and morphology was assessed by using a logistic model for
epeated measures with calculation of robust standard errors. A mul-
ivariable logistic model was fitted by including all variables with
P value of less than .1 on univariate analysis. The c statistic (for
iscrimination) and the shrinkage coefficient (for calibration) were
omputed for model validation. Finally, receiver operating char-
cteristic curve analysis was performed to identify the optimal
utoff points for postoperative right ventricular ejection fraction
nd PVR in predicting clinical failure at 12 months.
ABLE 2. Hemodynamic, cardiac magnetic resonance, echoc
ariable Preoperative, n  37 Discha
emodynamics
PVR (dyne · sec · cm5)† 1143 (782-1385) 296
mPAP (mm Hg)† 48 (36-59) 22
CO (L/min) 3.2 0.8 4.
CI (L · min1 · m2) 1.7  0.4 2.
RAP (mm Hg)† 7 (3-11) 2
MR
RV-EDV (mL) 113 40 7
RV-ESV (mL) 80 33 5
RV-EF (%) 30 11 3
RV-WT (mm) 8.4 1.3 7.
LV-EDV (mL) 88 29 10
LV-ESV (mL) 50 21 6
LV-EF (%) 43 13 4
chocardiography
RV-FAS (%) 24 10 3
TR 2-3‡ 29 (78.4%) 10
TAPSE (mm) 15 4 1
IVC diameter (mm) 22 6 1
IVC collapsibility 15 (40.5%) 31
EDEI 1 33 (89.2%) 5
YHA class
III/IV 36 (97.3%)
VR, Pulmonary vascular resistance; mPAP, mean pulmonary artery pressur
agnetic resonance; RV-EDV, right ventricular end-diastolic volume; RV
raction; RV-WT, right ventricular wall thickness; LV-EDV, left ventricular
entricular ejection fraction; RV-FAS, right ventricular fraction of area s
xcursion; IVC, inferior vena cava; EDEI, end-diastolic eccentricity index; N
ignificance if .0125 (4 comparisons) or .010 (5 comparisons). †Log tra
he valvular regurgitation area filled one third to two thirds of the right atr
ight atrial area or when systolic reflux in the hepatic veins was detectabAll analyses were performed with Stata 9.1 software (Stata n
64 The Journal of Thoracic and Cardiovascular Surgery ● Januorp, College Station, Tex). The Bonferroni correction for multi-
le tests was used for post-hoc comparisons.
esults
perative Outcomes and Late Deaths
here was 1 early death after discharge (postoperative day 12)
aused by cardiac tamponade, and 1 patient underwent bilat-
ral lung transplantation (postoperative day 4) because of re-
ractory acute right ventricular failure. In the postoperative
eriod, 2 patients had acute right ventricular failure and 3 had
eperfusion edema. The median stay in the intensive care unit
as 5 days, whereas the median hospital length of stay was
0 days. Over the entire study period, no patients underwent
eintervention because of recurrence of CTEPH. One late
oncardiac death (secondary to cancer) occurred at 8
onths’ follow-up.
emodynamic Efficacy of PEA
EA provided immediate and effective relief from pulmo-
ographic variables, and functional symptoms time course
 35 3 mo, n  35 12 mo, n  34 24 mo, n  34
409) 238 (170-392) 267 (157-429) 256 (168-427)
6) 20 (15-29) 22 (14-35) 19 (15-30)
.3 4.9 1.4 4.7 1.0 4.6  1.1
.6 2.6 0.5 2.5 0.4 2.4  0.5
1 (0-3) 2 (1-4) 2 (1-6)
5 73 20 74 17 107  54
2 45 19 42 13 59  38
39  12 44 10 46  11
.3 6.9 1.2 6.3 0.8 5.8  0.8
1 103 22 107 19 117  29
0 56 16 52 17 54  20
45  10 52 10 54  9
2 33 11 36 11 41  11
) 6 (17.1%) 8 (23.5%) 7 (20.6%)
14  3 15 2 16  3
15  4 14 3 15  3
) 32 (91.4%) 33 (97.1%) 30 (88.2%)
) 5 (14.3%) 6 (17.6%) 7 (20.6%)
5 (14.3%) 2 (5.9%) 4 (11.8%)
, cardiac output; CI, cardiac index; RAP, right atrial pressure; CMR, cardiac
right ventricular end-systolic volume; RV-EF, right ventricular ejection
iastolic volume; LV-ESV, left ventricular end-systolic volume; LV-EF, left
ge; TR, tricuspid regurgitation; TAPSE, tricuspid annular plane systolic
New York Heart Association functional class. *For Bonferroni correction
ed to be fitted into the regression model. ‡Tricuspid regurgitation  2 if
ricuspid regurgitation  3 when a jet filled greater than two thirds of the
reoperative versus 3 months.ardi
rge, n
(182-
(16-2
9  1
7  0
(0-5)
8 2
4  2
3  9
8  1
8 3
2  2
3  8
2  1
(28.6%
1  2
7  4
(88.6%
(14.3%
NA
e; CO
-ESV,
end-d
hrinkaary hypertension (Table 2): at discharge, PVR w a s d e -
ary 2007
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A
CDreased by almost 70%, and mean pulmonary artery
ressure was decreased by almost 50% compared with the
reoperative values. Cardiac index and cardiac output
hanged accordingly, whereas central venous pressure nor-
alized. All of these hemodynamic variables remained sta-
le over the entire study period.
ight Ventricular Response to Chronic Pressure
verload Relief
mmediately after the operation, right ventricular cavitary di-
ensions were significantly decreased, whereas left ventric-
lar systolic and diastolic volumes were increased (Table 2).
n contrast, right ventricular wall thickness remodeled over
longer period of time, and even though decreases in wall
hickness were significant only during the first 12 months
fter the operation, a trend of steady thinning was main-
ained for the entire study period (Table 2).
Global right ventricular systolic function, as expressed
y the right ventricular ejection fraction measured by means
f cardiac magnetic resonance, was significantly improved
t the third month of follow-up; this variable also continued
o show steady progress over the following 3 years, al-
hough this did not reach statistical significance (Table 2).
he longitudinal systolic function returned to preoperative
alues within 3 months after a transient decrease immedi-
ABLE 2. Continued
6 mo, n  21 P value over time
Preoperative vs
discharge Discha
306 (192-599) .001 .001
21 (16-35) .001 .001
4.2  0.8 .001 .001
2.2  0.3 .001 .001
2 (1-5) .001 .001
96  43 .001 .001
50  28 .001 .001
50  9 .001 .186
5.6  0.8 .001 .028
113 33 .001 .001
52  25 .001 .001
56  11 .001 .2
38  10 .001 .001
7 (33.3%) .001 .001
17  3 .001 .001
17  5 .001 .001
16 (76.2%) .001 .001
3 (14.3%) .001 .001
3 (14.3%) .001 .001§tely after the operation, whereas the radial systolic function r
The Journal of Thoracicas significantly increased at discharge evaluation and con-
inued to improve throughout follow-up (although not sta-
istically significant). Left ventricular ejection fraction mod-
rately increased over the entire study period, reaching
tatistical significance only at 1 year’s follow-up.
Immediately after the operation, tricuspid regurgitation
adically improved. Also, the inferior vena cava regained
ull collapsibility, and its diameter greatly decreased, with
o significant change with future measurements (Table 2).
n the first few postoperative days, the abnormal interven-
ricular septum displacement rapidly reversed in the major-
ty of patients, and the geometry of the left ventricle steadily
mproved, with a greater and more protracted increase in
nd-diastolic volumes compared with end-systolic volumes
Table 2).
unctional Status
fter discharge, functional status steadily improved over the
rst 12 months of follow-up, with no late changes. Through-
ut the entire follow-up period, no patients died from car-
iac causes.
ostoperative Determinants of Clinical Failure
y using univariate analysis, higher right ventricular dimen-
ions, lower left ventricular end-diastolic volume, and lower
P value for post-hoc comparison*
s 3 mo 3 mo vs 12 mo 12 mo vs 24 mo 24 mo vs 36 mo
.164 .2 .103
.084 .2 .2
.155 .2 .032
.039 .2 .022
9 .074 .2 .2
3 .2 .002 .2
9 .2 .015 .2
1 .016 .139 .2
1 .001 .033 .2
.2 .065 .2
4 .096 .2 .2
0 .008 .2 .2
.075 .012 .032
9 .2 .2 .031
1 .017 .064 .2
1 .2 .113 .059
.2 .2 .048
.2 .2 .2
.200 .160 .2rge v
.2
.2
.2
.2
.00
.13
.01
.00
.00
.2
.04
.13
.2
.14
.00
.00
.2
.2ight and left ventricular ejection fraction (measured at each
and Cardiovascular Surgery ● Volume 133, Number 1 165
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A
CDime point during follow-up) were significantly associated
ith an increased probability for the patient to be within
YHA functional class III or IV rather than I or II (Table 3).
nly left ventricular end-systolic volume did not correlate
ith NYHA class. By using multivariate analysis, right
entricular fractional area shrinkage and PVR were the only
redictors of NYHA class after PEA (Table 3).
By means of receiver operating characteristic analysis,
e showed that PVR values of greater than 509 dyne ·
ec · cm5 and a right ventricular ejection fraction of 24%
r less at discharge predicted clinical failure at 12 months’
ollow-up (PVR: specificity, 96.9%; sensitivity, 60%; right
entricular ejection fraction: specificity, 74.2%; sensitivity,
5%).
iscussion
TEPH results in chronic right heart pressure overload,
hich leads to altered right and left ventricular geometry
nd hemodynamics. Long-term outcome and functional sta-
us are determined by the ability of the right ventricle to
ABLE 3. Independent postoperative determinants of clini
haracteristic
NYHA I-II,
no. visit  116
NYHA III-IV
no. visit  5
emodynamics
PVR (dyne · sec · cm5)§ 241 (160-380) 1090 (782-133
mPAP (mm Hg)§ 19 (14-27) 48 (34-57)
CO (L/min) 4.8 1.1 3.3 0.8
CI (L · min1 · m2) 2.5  0.4 1.8 0.4
RAP 2 vs 2 37 (31.9%) 37 (64.9%)
MR
RV-EDV (mL) 83 35 111  41
RV-ESV (mL) 46 22 79 34
RV-EF (%) 45 11 30 11
RV-WT (mm) 6.4 1.1 8.1 1.3
LV-EDV (mL) 107 26 89 27
LV-ESV (mL) 54 19 50 20
LV-EF (%) 51 10 44 13
chocardiography
RV-EDD (mm) 31 5 40  9
RV-FAS (%) 38 11 24 9
TR grade 2-3 vs 0-1 18 (15.5%) 39 (68.4%)
TAPSE (mm) 16 3 14  4
IVC diameter (mm) 15 3 22  6
IVC collapsibility, yes vs no 101 (87.1%) 25 (43.9%)
EDEI 1 14 (12.1%) 40 (70.2%)
YHA, New York Heart Association functional class; CI, confidence interva
O, cardiac output; CI, cardiac index; RAP, right atrial pressure; CMR, cardi
ight ventricular end-systolic volume; RV-EF, right ventricular ejection fracti
olume; LV-ESV, left ventricular end-systolic volume; LV-EF, left ventricular
entricular fraction of area shrinkage; TR, tricuspid regurgitation; TAPS
nd-diastolic eccentricity index. *Multivariable Logistic model: P  .00
oefficient 0.72. †Based on robust standard errors. ‡The association is inemodel in the face of an increased hemodynamic load.8,9 i
66 The Journal of Thoracic and Cardiovascular Surgery ● JanuWe chose to evaluate the extent and time course of
natomic and functional derangements induced by CTEPH
hat are reversible after PEA to determine how durable this
eversal is over time and to determine whether these
hanges in the right ventricle relate to improved functional
tatus of the patients.
To study the right ventricle, we used a comprehensive
pproach integrating hemodynamic variables, functional
ata, and volumetric measurements obtained with a nongeo-
etric technique.
Although previous investigators described cardiac changes
ccurring early after PEA,10,11 there is no evidence of
lobal reverse right ventricular remodeling in short-term
nd midterm periods after PEA.
We and others previously reported success of PEA in
he reduction of pulmonary hypertension in patients with
TEPH.3,12-15 Regardless of the severity of preoperative
isease in our study population, PVR and mean pulmonary
rtery pressure returned to normal values, cardiac index
arkedly increased, and right atrial pressures normal-
ailure: Univariable and multivariable analysis
Univariable analysis Multivariable analysis*
Odds ratio
(95% CI)† P value†‡
Odds ratio
(95% CI) P value
46.2 (10.3-206.3) .001 28.03 (1.10-714) .044
63.3 (10.9-369.3) .001
0.2 (0.1-0.3) .001 0.47 (0.17-1.32) .154
0.02 (0.01-0.10) .001
5.8 (2.6-13.2) .001 0.52 (0.10-2.78) .443
1.02 (1.01-1.03) .001
1.04 (1.02-1.07) .001
0.88 (0.84-0.93) .001
3.3 (2.0-5.4) .001
0.97 (0.95-0.98) .001 1.00 (0.99-1.01) .842
0.99 (0.97-1.01) .228
0.94 (0.91-0.98) .01
1.2 (1.1-1.4) .001 0.97 (0.87-1.11) .820
0.9 (0.8-0.9) .001 0.92 (0.86-0.99) .042
19.3 (6.9-54.2) .001 1.23 (0.21-7.29) .816
0.9 (0.7-1) .038 1.18 (0.93-1.50) .181
1.5 (1.2-1.7) .001
0.04 (0.01-0.12) .001
37.39 (13.60-106.0) .001
, pulmonary vascular resistance; mPAP, mean pulmonary artery pressure;
gnetic resonance; RV-EDV, right ventricular end-diastolic volume; RV-ESV,
-WT, right ventricular wall thickness; LV-EDV, left ventricular end-diastolic
on fraction; RV-EDD, right ventricular end-diastolic diameter; RV-FAS, right
uspid annular plane systolic excursion; IVC, inferior vena cava; EDEI,
del validation: discrimination, c statistic  0.94; calibration, shrinkage
dent on time of visit. §Log transformed to be fitted in the regression model.cal f
,
7
3)
l; PVR
ac ma
on; RV
ejecti
E, tric
1. Mozed. These variables remained stable throughout the
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A
CDntire follow-up period. Right ventricular reverse remodel-
ng was complete and stable over time in the vast majority
f our patients. Thus no patient should be denied PEA based
n preoperative hemodynamic impairment.
We showed that full recovery of right and left ventricular
eometry is achieved soon after PEA, whereas regression of
oncentric hypertrophy and restoration of full right and left
ystolic function require a longer period of time. After
orrection of severe chronic pressure overload, right ven-
ricular reverse remodeling is not limited by pre-existing
entricular size, shape, and function before correction. We
bserved a modest increase in right ventricular end-diastolic
olume at 2 years’ follow-up, as well as an insignificant
ncrease in systolic volume. This can be attributed to the
resence of outliers (patients with little improvement)
ithin the population with the longest follow-up.
We showed that patients with CTEPH have a high op-
rability rate (75%) and that hemodynamic and functional
mprovement after PEA is remarkable and stable over time.
owever, there is a small subgroup of patients who do not
enefit from PEA.15,16 This subgroup is usually affected by
ither diffuse chronic microvascular thromboembolism or
y a combination of different types of pulmonary hyperten-
ion with a predominance of microvascular disease.17
We found that the degree of postoperative residual PVR
as strongly predictive of postoperative functional im-
airment, and a predischarge value of greater than 509
yne · sec · cm5 was a predictor of clinical failure at 1
ear’s follow-up, supporting findings from Jamieson and
olleagues.14 However, very sick and well-selected patients
ould be significantly benefited in their quality of life and
verall survival, even from a moderate reduction in PVR.
hus surgical intervention should not necessarily be contra-
ndicated in those cases in which pulmonary hypertension is
ut of balance with the angiographic appearance, unless
hromboembolic lesions are very distal and represent only a
inor component of the pathology of the patients’ pulmo-
ary disease. In cases in which PVR at discharge is greater
han 509 dyne · sec · cm5, adequate medical therapy
hould be instituted, and lung transplantation should be
onsidered only in patients with progressive and severe
unctional and hemodynamic impairment.
To differentiate between the patients with a full recovery
nd those individuals who only partially benefited from
urgical intervention, we defined the persistence of NYHA
lass III or IV or death from right ventricular failure 1 year
ostoperatively as clinical failure. However, we believe that
n patients with extreme CTEPH, the relative reduction in
VR might be important. Even though the postoperative
VR might not be low enough to warrant a full recovery,
hese patients could still benefit in terms of survival and
ong-term functional status compared with those who only
eceive medical treatment.2
The Journal of ThoracicIn conclusion, right ventricular reverse remodeling
ccurred and was complete in the vast majority of pa-
ients who underwent PEA and was independent of pre-
perative geometry and function. Although reversal of
eometric changes occurred early after surgical
ntervention, regression of hypertrophy and restoration of
ormal systolic function took place mainly during the
rst postoperative year, with a tendency to continue up to
he third year of follow-up. The major determinant of
ight ventricular reverse remodeling is the restoration of
hysiologic pulmonary artery pressure, a condition
chieved by the performance of a successful PEA.
We thank T. M. Egan, University of North Carolina at Chapel
ill, for scientific and editorial assistance.
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iscussion
r Michael S. Mulligan (Seattle, Wash). The correlation of post-
perative patient functional status and right heart recovery is
ntuitive but has not been documented so clearly before. You are
o be commended for your detailed and long-term follow-up.
hose of us who care for these patients and perform this operation
ave observed these findings, but your documentation of these
henomena will be an important contribution to our understanding
f this disease and the physiologic effects of unloading the right
eart in general.
There would be tremendous value if these data could be used to
redict and not simply document a successful outcome. You have
ttempted to identify predictors of clinical failure. You had full
ets of data on patients preoperatively; however, the variables
xamined were often postoperative assessments. As such, you
ight answer whether a patient will experience long-term failure
ut not whether he or she was an appropriate candidate before the
peration. I have a few questions.
First, do you have any insights into how your findings might
elp refine patient selection? For example, did you make any
ttempt to correlate your echocardiographic/catheter and MRI
ndings with other established outcome predictors, such as the
ype of disease by Jamieson classification and how many of the
atients with acute or late failure had type 3 or type 4 disease?
Second, so long as you normalize PVR with relief of anatomic
bstructions, right heart function will almost invariably recover,
ut does your experience allow you to identify any patients in
hom the right heart will not recover? This issue sometimes arises
n considered isolated lung transplantation for patients with long-
tanding and severe pulmonary hypertension.
Finally, is there a point at which you believe the severity of left
entricular dysfunction precludes safe PEA, and does that estimate
ary when considering lung transplantation for such patients
herein PVR decreases even further? Such information might also u
68 The Journal of Thoracic and Cardiovascular Surgery ● Janue useful in guiding the decision between referral for lung versus
eart-lung transplantation.
Again, congratulations on your presentation and your excellent
esults.
Dr D’Armini. Regarding the first question, in our study we had
nly 1 patient with type 4 lesions and 3 patients with type 3
esions. Because of the small number of individuals, we were not
ble to perform any statistical analyses. However, I believe that
atients with type 3 lesions, even if surgically more challenging
han patients with type 1 or type 2 lesions, might still regain full
natomic and functional recovery of the right ventricle, as long as
he operation is performed well.
With regard to the second question, because our primary ob-
ectives were to assess the extent and time course of right ventric-
lar reverse remodeling and to analyze the correlation between
ight ventricular remodeling and functional status, we did not
erform this study. However, I think it might be possible to do
sing the data that we have in our registry.
About the last question, left ventricular dysfunction, manifested
ainly as moderate systolic impairment caused by low left ven-
ricular preload, is a consequence of right ventricular remodeling.
ith the removal of the pulmonary obstructing lesions, CTEPH-
nduced changes of the right ventricle reverse, left ventricular
reload increases, and left systolic function improves. In our
xperience left ventricular dysfunction has never been a problem
uring the postoperative period.
Dr Friedrich Wilhelm Mohr (Leipzig, Germany). I had a little
oncern looking at your tricuspid valves, even in follow-up. You
howed nicely that the right ventricular function improved, but in
ollow-up all the tricuspid valves you showed had a significant
egurgitation. Why do you hesitate to do a simple tricuspid annu-
oplasty?
Dr D’Armini. We did not perform tricuspid annuloplasty be-
ause the tricuspid valve regurgitation was always deemed func-
ional. In fact, after the operation, less than 10% of patients had
esidual severe regurgitation, and these patients oftentimes also
ad high pulmonary pressures. In these instances tricuspid regur-
itation might have been helpful in preventing acute right ventric-
lar failure in the perioperative period.
ary 2007
